Literature DB >> 10387144

Inappropriate implantable defibrillator discharge caused by a retained pacemaker lead fragment.

L Lickfett1, C Wolpert, W Jung, S Spehl, L Pizzulli, B Esmailzadeh, B Lüderitz.   

Abstract

INTRODUCTION: Inappropriate discharge is still a major issue of implantable cardioverter defibrillator therapy. The diagnostic options of modern devices facilitate classification of the underlying abnormality. METHODS AND
RESULTS: A 65-year-old woman with depressed left ventricular performance received spurious shocks from an ICD, implanted for ventricular tachycardia. A lead fragment of an explanted VVI pacemaker system could be identified as cause of erroneous ventricular fibrillation detection by the ICD. The electrical noise caused by interaction between the lead remnant and the ICD lead was detectable even on the surface ECG.
CONCLUSION: Based on our findings, removal of fragmented lead material should be considered prior to ICD implantation, to avoid potentially adverse and harmful interactions with ICD systems.

Entities:  

Mesh:

Year:  1999        PMID: 10387144     DOI: 10.1023/a:1009877715662

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  11 in total

1.  Case report: inappropriate discharge of an implantable cardioverter-defibrillator caused by the combined count criterion.

Authors:  C Wolpert; W Jung; S Spehl; T Korte; B Lüderitz
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

2.  Limitations and late complications of third-generation automatic cardioverter-defibrillators.

Authors:  S O Nunain; M Roelke; T Trouton; S Osswald; Y H Kim; G Sosa-Suarez; D R Brooks; B McGovern; M Guy; D F Torchiana
Journal:  Circulation       Date:  1995-04-15       Impact factor: 29.690

3.  Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias.

Authors:  W Jung; B Lüderitz
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

4.  Combined use of non-thoracotomy cardioverter defibrillators and endocardial pacemakers.

Authors:  H H Noguera; A O Peralta; R M John; F J Venditti; D T Martin
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

Review 5.  Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators.

Authors:  M J Reiter; D E Mann
Journal:  J Cardiovasc Electrophysiol       Date:  1996-06

6.  Electrical proarrhythmia: induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator.

Authors:  C Wolpert; W Jung; C Scholl; S Spehl; J Cyran; B Lüderitz
Journal:  J Cardiovasc Electrophysiol       Date:  1998-08

7.  Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.

Authors:  C D Swerdlow; P S Chen; R M Kass; J R Allard; C T Peter
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

8.  Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.

Authors:  W Grimm; B F Flores; F E Marchlinski
Journal:  Pacing Clin Electrophysiol       Date:  1992-11       Impact factor: 1.976

9.  Incidence of ICD lead related complications during long-term follow-up: comparison of epicardial and endocardial electrode systems.

Authors:  T Korte; W Jung; S Spehl; C Wolpert; R Moosdorf; M Manz; B Lüderitz
Journal:  Pacing Clin Electrophysiol       Date:  1995-11       Impact factor: 1.976

10.  Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers.

Authors:  R Brooks; H Garan; B A McGovern; J N Ruskin
Journal:  Am Heart J       Date:  1995-01       Impact factor: 4.749

View more
  1 in total

1.  Incessant ventricular tachycardia, refractory to catheter ablation, in an ICD patient terminated by ICD lead extraction: a case report.

Authors:  Corinna Lenz; Thomas Dietze; Michael Möller; Wolfgang Schöbel; Jens Wicke; Hans-Jörg Kellner; Rainer Gradaus; Jörg Neuzner
Journal:  Clin Res Cardiol       Date:  2009-08-28       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.